Long Non-Coding RNA TTN-AS1 Serves as a Competing Endogenous RNA of miR-195 to Facilitate Clear Cell Renal Cell Carcinoma Progression.

Lin, Keng; Chen, Hao; Su, Chunyan; Zhu, Huanjin; Lai, Changchun; Shi, Yaling

Lin, Keng; Chen, Hao; Su, Chunyan; Zhu, Huanjin; Lai, Changchun; Shi, Yaling.

Afiliação

Lin K; Clinical Laboratory, Maternal and Children Health Care Hospital (Huzhong Hospital) of Huadu, Guangzhou 510800, People's Republic of China.
Chen H; Clinical Laboratory, The Affiliated Oncology Hospital of Sun Yat-sen University, Guangzhou 510000, People's Republic of China.
Su C; Clinical Laboratory, The Second People's Hospital of Gaozhou, Gaozhou 525200, People's Republic of China.
Zhu H; Clinical Laboratory, Maternal and Children Health Care Hospital (Huzhong Hospital) of Huadu, Guangzhou 510800, People's Republic of China.
Lai C; Clinical Laboratory, People's Hospital of Maoming, Maoming 525000, People's Republic of China.
Shi Y; Clinical Laboratory, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510000, People's Republic of China.

Cancer Manag Res ; 12: 3091-3097, 2020.

Article em En | MEDLINE | ID: mdl-32440207

Palavras-chave

cell cycle; clear cell renal cell carcinoma; long non-coding RNA TTN-AS1; miR-195; ï»¿cyclin D1

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancer Manag Res Ano de publicação: 2020 Tipo de documento: Article País de publicação: Nova Zelândia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google